BYSI BeyondSpring
- 2.130
- -0.140-6.17%
- 2.120
- -0.010-0.45%
BeyondSpring News
IBio, Mesoblast, Kodiak Sciences Among Healthcare Movers
BeyondSpring Says First Patient Dosed in Phase 2 Trial of Lung Cancer Combination Treatment
BeyondSpring (BYSI) said Monday that the first patient has been dosed in a phase 2 investigator-initiated trial of pembrolizumab, plinabulin plus etoposide/platinum for first-line extensive-stage smal
BeyondSpring Announces First Patient Dosed With Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer
BeyondSpring Inc. (NASDAQ: BYSI) today announced that the first patient has been dosed in a Phase 2 investigator-initiated trial (IIT) with Pembrolizumab, Plinabulin, BeyondSpring's lead asset, plus Etoposide/Platinum (EP) for first-line (1L) Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) [NCT05745350].
BeyondSpring Announces Executive Leadership Change
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersPsyence Biomedical (NASDAQ:PBM) stock moved upwards by 35.3% to $1.38 during Thursday's regular session. The market value of their outstanding shares is at $18.4 million. ZyVersa Therapeutics (
BeyondSpring, EnVVeno Medical, Aptorum Group Among Healthcare Movers
BYSI, PHUN and DTSS Among Pre-market Losers
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersNKGen Biotech (NASDAQ:NKGN) shares increased by 69.4% to $1.46 during Wednesday's pre-market session. The market value of their outstanding shares is at $31.9 million. Creative Medical Tech (NA
Top Premarket Decliners
Entravision Communications (EVC) shares slumped 50% Wednesday premarket after the company posted a wider Q4 loss. Thor Industries (THO) shares fell 17% after reporting weaker fiscal Q2 financial resul
Individual Investors Who Hold 59% of BeyondSpring Inc. (NASDAQ:BYSI) Gained 125%, Insiders Profited as Well
Key Insights Significant control over BeyondSpring by individual investors implies that the general public has more power to influence management and governance-related decisions 41% of the business
EYEN, BYSI and FENG Among Mid-day Movers
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersSunshine Biopharma (NASDAQ:SBFM) stock rose 142.3% to $0.11 during Tuesday's regular session. The company's market cap stands at $5.9 million. Ocean Biomedical (NASDAQ:OCEA) shares rose 54.65%
BeyondSpring Regains Nasdaq Compliance as Price Surges Above $1
BeyondSpring Regains Compliance With Nasdaq Minimum Bid Price and Periodic Filing Requirements
FLORHAM PARK, N.J., Feb. 26, 2024 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) ("BeyondSpring" or the "Company"), a global clinical-stage biopharmaceutical company focused on using a groundbrea
Express News | BeyondSpring Disclosed On January 10, 2024, The Arbitral Tribunal At China International Economic And Trade Arbitration Committee Issued A Final Award, Denying All Claims Made By Hengrui
BeyondSpring Gets Nasdaq Delinquency Notice
BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K
NEW YORK, January 10, 2024 – BeyondSpring Inc. (NASDAQ: BYSI) ("BeyondSpring" or the "Company"), a global clinical-stage biopharmaceutical company focused on using a groundbreaking technology platform
BeyondSpring Receives Notification From Nasdaq for Breaching Minimum Bid Price Requirements
BeyondSpring (BYSI) reported late Monday non-compliance of its shares with the minimum closing bid price of $1.00 per share Nasdaq listing rule. The company said the closing bid price was below the th
Promising Potential of Plinabulin Reinforces Buy Recommendation for Beyondspring
BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity...
Analysis
Price Target
No Data
